SBC Medical Group Holdings Incorporated (SBCWW) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+1870.9%

$9.26

vs $0.47 price

Levered DCF

$8.42

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

2.71

Grey zone

Rating

A+

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	0.41×	0.5×	0.15×	0.08×
P/B	0.08×	0.12×	0.04×	0×
P/S	0.12×	0.11×	0.03×	0×
EV / EBITDA	-1.07×	-1.16×	-0.86×	-1.33×
Gross margin	73.3%	76.0%	70.9%	52.8%
Operating margin	38.9%	34.2%	36.5%	11.6%
Net margin	29.4%	22.7%	20.3%	3.6%
Current ratio	3.78×	3.01×	1.79×	1.12×
Debt / equity	0.21×	0.06×	0.16×	0.15×
Interest coverage	420.26×	2,484.23×	1,560.1×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	20.5%	23.9%	27.7%	6.0%
Return on invested capital	12.6%	21.3%	21.3%	3.6%
Return on assets	13.4%	17.5%	15.2%	2.8%
Free cash flow yield	174.8%	224.0%	644.5%	-4837.1%
Earnings yield	243.9%	201.1%	643.0%	1222.2%
Enterprise value	-$91.2M	-$89.6M	-$74M	-$35.1M
Net debt / EBITDA	-1.32×	-1.46×	-0.93×	-1.35×
Cash conversion cycle (days)	-5	-11	-52	29